4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001062993-23-013930
Chief Financial Officer sold 134,961 shares at $8.14 ($1,098,583)
- Chief Financial Officer acquired 134,961 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
PETERSON TYCHO · Chief Financial Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-06-20 | Exercise or conversion : show line 1 in the form 10b5-1 | +134,961 | $7.30 | $985,215 | 534,180 | D |
| 2023-06-20 | Sale : show line 2 in the form 10b5-1 | −70,000 | $8.14 | $569,800 | 464,180 | D |
| 2023-06-20 | Sale : show line 3 in the form 10b5-1 | −64,961 | $8.14 | $528,783 | 399,219 | D |
| Open-market sales · 134,961 sh · avg $8.14 · $1,098,583 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-06-20 | Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (right to buy) | −134,961 | 447,868 | D |
Loading xslF345X04/form4.xml…